These familial mutations impair the perforin-dependent cytolytic pathway, which prevents cytotoxic lymphocytes from effectively destroying mutated antigen-presenting cells, resulting in excessive release of pro-inflammatory cytokines that drive clinical manifestations of MAS [5]. This evidence concerns the gene PRF1 and macrophage activation syndrome.